Cytovale logo

Cytovale

At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.

121 employees · est. 2013 · South San Francisco, United...

VS
Volition logo

Volition

Revolutionizing early disease diagnosis for a brighter tomorrow

86 employees · est. 2010 · Henderson, United States

Volition is the older company (2013 vs 2010).

Side-by-Side Comparison

Cytovale Volition
Founded
2013 2010 older
Headquarters
South San Francisco, United States Henderson, United States
Employees
121 86
Industry
AI, Health Care, Life Sciences Not tracked yet
Funding Stage
Series C IPO
Total Funding
$128.59M $69.10M
Funding Rounds
9 15
Services
Not tracked yet Development of epigenetic diagnostic tests, Blood-based assays for disease detection, Capture and analysis of circulating tumor DNA, Providing diagnostic solutions for veterinary medicine
Target Customers
Not tracked yet Clinicians, Veterinarians, Pharmaceutical Companies, Biotech Researchers, Healthcare Institutions
Taxonomy
Medical Diagnostics, Cell Mechanics, Sepsis Diagnosis, Immune-mediated Diseases, Early Detection Technologies, Biomechanical Evaluation, FDA Cleared, Rapid Diagnostics, San Francisco-based Company, Immune Response, Critical Care, Sepsis Mortality Early Disease Diagnosis, Epigenetics, Cancer Detection, Liquid Biopsy, Nucleosome Quantification, Biomarkers, Veterinary Medicine, Human Medicine, Cancer Screening, Nucleosomics, Routine Blood Tests, Cost-effective Diagnostics, Disease Progression Monitoring, Capture-PCR Technology
Website
cytovale.com volition.com
Cytovale logo

About Cytovale

Cytovale: Cytovale, a medical diagnostics company founded in 2013, is focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test pioneers a new way of quickly and accurately analyzing white blood cells to stratify a pa...

Volition logo

About Volition

Volition, established in 2010, is on a mission to transform the landscape of disease diagnosis through its cutting-edge epigenetic technologies. Headquartered in the United States and listed on NYSE AMERICAN under VolitionRX Limited (VNRX), this innovative company seeks to change how diseases such a...

We will tell you when either one moves

BounceWatch watches Cytovale and Volition for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cytovale and Volition — by email.

Frequently Asked Questions

Cytovale — At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases. . Volition — Revolutionizing early disease diagnosis for a brighter tomorrow. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cytovale has raised $128.59M while Volition has raised $69.10M.
Cytovale and Volition operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cytovale with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cytovale on 12 Sep 2024, and Volition on 21 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy